Pericardial Effusion Revealing Cardiac and Thyroid AA Amyloidosis in Chronic Inflammatory Bowel Disease Complicated by Hypothyroidism Discovered Incidentally
Published: 2024-03-28
Page: 42-46
Issue: 2024 - Volume 7 [Issue 1]
Bettar Mohamed Ghoulame
*
Department of Cardiology, Ibn Rochd University Hospital, Casablanca, Morocco.
M. Njie
Department of Cardiology, Ibn Rochd University Hospital, Casablanca, Morocco.
J. Moyambe
Department of Cardiology, Ibn Rochd University Hospital, Casablanca, Morocco.
Charfo B Mahamado
Department of Cardiology, Ibn Rochd University Hospital, Casablanca, Morocco.
Haboub Mérieme
Faculty of Medicine and Pharmacy of Casablanca, Morocco.
Arous Salim
Faculty of Medicine and Pharmacy of Casablanca, Morocco.
Med Ghali Bennouna
Faculty of Medicine and Pharmacy of Casablanca, Morocco.
Rachida Habbal
Faculty of Medicine and Pharmacy of Casablanca, Morocco.
*Author to whom correspondence should be addressed.
Abstract
The association of pericardial effusion with ventricular hypertrophy is one of the signs suggestive of cardiac amyloidosis, according to the literature. We report a case of cardiac and thyroid AA amyloidosis in a 65-year-old patient followed for chronic inflammatory bowel disease complicated by hypothyroidism revealed by a large pericardial effusion. We report a case of a 65-year-old postmenopausal patient followed for constipation for 3 years without any other particular history, who consulted for dyspnea evolving for 20 days initially with effort then becoming at rest evolving in a context of alteration of the general condition. Our report is the case of type AA amyloidosis probably secondary to chronic intestinal inflammation responsible for cardiac damage expressed by left ventricular hypertrophy and thyroid damage leading to hypothyroidism responsible for large pericardial effusion.
Keywords: Pericardial effusion, AA amyloidosis, hypothyroidism